nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—Anxiety—Cisplatin—testicular cancer	0.00213	0.00213	CcSEcCtD
Treprostinil—Anaemia—Etoposide—testicular cancer	0.00213	0.00213	CcSEcCtD
Treprostinil—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00212	0.00212	CcSEcCtD
Treprostinil—Dyspnoea—Ifosfamide—testicular cancer	0.00212	0.00212	CcSEcCtD
Treprostinil—Discomfort—Cisplatin—testicular cancer	0.00211	0.00211	CcSEcCtD
Treprostinil—Vomiting—Vinblastine—testicular cancer	0.00209	0.00209	CcSEcCtD
Treprostinil—Malaise—Etoposide—testicular cancer	0.00208	0.00208	CcSEcCtD
Treprostinil—Decreased appetite—Ifosfamide—testicular cancer	0.00207	0.00207	CcSEcCtD
Treprostinil—Headache—Vinblastine—testicular cancer	0.00206	0.00206	CcSEcCtD
Treprostinil—Abdominal pain—Dactinomycin—testicular cancer	0.00205	0.00205	CcSEcCtD
Treprostinil—Body temperature increased—Dactinomycin—testicular cancer	0.00205	0.00205	CcSEcCtD
Treprostinil—Fatigue—Ifosfamide—testicular cancer	0.00205	0.00205	CcSEcCtD
Treprostinil—Oedema—Cisplatin—testicular cancer	0.00205	0.00205	CcSEcCtD
Treprostinil—Infection—Cisplatin—testicular cancer	0.00204	0.00204	CcSEcCtD
Treprostinil—Pain—Ifosfamide—testicular cancer	0.00203	0.00203	CcSEcCtD
Treprostinil—Cardiac failure—Doxorubicin—testicular cancer	0.00203	0.00203	CcSEcCtD
Treprostinil—Loss of consciousness—Etoposide—testicular cancer	0.00202	0.00202	CcSEcCtD
Treprostinil—Cough—Etoposide—testicular cancer	0.00201	0.00201	CcSEcCtD
Treprostinil—Thrombocytopenia—Cisplatin—testicular cancer	0.00201	0.00201	CcSEcCtD
Treprostinil—Tachycardia—Cisplatin—testicular cancer	0.002	0.002	CcSEcCtD
Treprostinil—Asthenia—Bleomycin—testicular cancer	0.002	0.002	CcSEcCtD
Treprostinil—Dehydration—Epirubicin—testicular cancer	0.00199	0.00199	CcSEcCtD
Treprostinil—Pain in extremity—Doxorubicin—testicular cancer	0.00198	0.00198	CcSEcCtD
Treprostinil—Pruritus—Bleomycin—testicular cancer	0.00197	0.00197	CcSEcCtD
Treprostinil—Feeling abnormal—Ifosfamide—testicular cancer	0.00196	0.00196	CcSEcCtD
Treprostinil—Chest pain—Etoposide—testicular cancer	0.00196	0.00196	CcSEcCtD
Treprostinil—Nausea—Vinblastine—testicular cancer	0.00196	0.00196	CcSEcCtD
Treprostinil—Anorexia—Cisplatin—testicular cancer	0.00195	0.00195	CcSEcCtD
Treprostinil—Hypokalaemia—Epirubicin—testicular cancer	0.00195	0.00195	CcSEcCtD
Treprostinil—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00194	0.00194	CcSEcCtD
Treprostinil—Discomfort—Etoposide—testicular cancer	0.00194	0.00194	CcSEcCtD
Treprostinil—Hypotension—Cisplatin—testicular cancer	0.00192	0.00192	CcSEcCtD
Treprostinil—Abdominal discomfort—Methotrexate—testicular cancer	0.0019	0.0019	CcSEcCtD
Treprostinil—Abdominal pain—Ifosfamide—testicular cancer	0.00188	0.00188	CcSEcCtD
Treprostinil—Body temperature increased—Ifosfamide—testicular cancer	0.00188	0.00188	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00187	0.00187	CcSEcCtD
Treprostinil—Infection—Etoposide—testicular cancer	0.00187	0.00187	CcSEcCtD
Treprostinil—Asthenia—Dactinomycin—testicular cancer	0.00186	0.00186	CcSEcCtD
Treprostinil—Influenza—Epirubicin—testicular cancer	0.00185	0.00185	CcSEcCtD
Treprostinil—Dehydration—Doxorubicin—testicular cancer	0.00184	0.00184	CcSEcCtD
Treprostinil—Paraesthesia—Cisplatin—testicular cancer	0.00184	0.00184	CcSEcCtD
Treprostinil—Thrombocytopenia—Etoposide—testicular cancer	0.00184	0.00184	CcSEcCtD
Treprostinil—Tachycardia—Etoposide—testicular cancer	0.00183	0.00183	CcSEcCtD
Treprostinil—Dyspnoea—Cisplatin—testicular cancer	0.00183	0.00183	CcSEcCtD
Treprostinil—Hypokalaemia—Doxorubicin—testicular cancer	0.0018	0.0018	CcSEcCtD
Treprostinil—Anorexia—Etoposide—testicular cancer	0.00179	0.00179	CcSEcCtD
Treprostinil—Decreased appetite—Cisplatin—testicular cancer	0.00178	0.00178	CcSEcCtD
Treprostinil—Bronchitis—Epirubicin—testicular cancer	0.00178	0.00178	CcSEcCtD
Treprostinil—Diarrhoea—Dactinomycin—testicular cancer	0.00178	0.00178	CcSEcCtD
Treprostinil—Pneumonia—Methotrexate—testicular cancer	0.00177	0.00177	CcSEcCtD
Treprostinil—Vomiting—Bleomycin—testicular cancer	0.00177	0.00177	CcSEcCtD
Treprostinil—Depression—Methotrexate—testicular cancer	0.00176	0.00176	CcSEcCtD
Treprostinil—Hypotension—Etoposide—testicular cancer	0.00176	0.00176	CcSEcCtD
Treprostinil—Rash—Bleomycin—testicular cancer	0.00175	0.00175	CcSEcCtD
Treprostinil—Pain—Cisplatin—testicular cancer	0.00175	0.00175	CcSEcCtD
Treprostinil—Dermatitis—Bleomycin—testicular cancer	0.00175	0.00175	CcSEcCtD
Treprostinil—Influenza—Doxorubicin—testicular cancer	0.00171	0.00171	CcSEcCtD
Treprostinil—Asthenia—Ifosfamide—testicular cancer	0.00171	0.00171	CcSEcCtD
Treprostinil—Feeling abnormal—Cisplatin—testicular cancer	0.00169	0.00169	CcSEcCtD
Treprostinil—Paraesthesia—Etoposide—testicular cancer	0.00169	0.00169	CcSEcCtD
Treprostinil—Pruritus—Ifosfamide—testicular cancer	0.00168	0.00168	CcSEcCtD
Treprostinil—Haematuria—Methotrexate—testicular cancer	0.00168	0.00168	CcSEcCtD
Treprostinil—Dyspnoea—Etoposide—testicular cancer	0.00167	0.00167	CcSEcCtD
Treprostinil—Epistaxis—Methotrexate—testicular cancer	0.00166	0.00166	CcSEcCtD
Treprostinil—Pneumonia—Epirubicin—testicular cancer	0.00166	0.00166	CcSEcCtD
Treprostinil—Nausea—Bleomycin—testicular cancer	0.00165	0.00165	CcSEcCtD
Treprostinil—Vomiting—Dactinomycin—testicular cancer	0.00165	0.00165	CcSEcCtD
Treprostinil—Bronchitis—Doxorubicin—testicular cancer	0.00165	0.00165	CcSEcCtD
Treprostinil—Rash—Dactinomycin—testicular cancer	0.00164	0.00164	CcSEcCtD
Treprostinil—Decreased appetite—Etoposide—testicular cancer	0.00163	0.00163	CcSEcCtD
Treprostinil—Diarrhoea—Ifosfamide—testicular cancer	0.00163	0.00163	CcSEcCtD
Treprostinil—Body temperature increased—Cisplatin—testicular cancer	0.00162	0.00162	CcSEcCtD
Treprostinil—Fatigue—Etoposide—testicular cancer	0.00162	0.00162	CcSEcCtD
Treprostinil—Pain—Etoposide—testicular cancer	0.00161	0.00161	CcSEcCtD
Treprostinil—Urinary tract infection—Epirubicin—testicular cancer	0.0016	0.0016	CcSEcCtD
Treprostinil—Haemoglobin—Methotrexate—testicular cancer	0.00159	0.00159	CcSEcCtD
Treprostinil—Haemorrhage—Methotrexate—testicular cancer	0.00158	0.00158	CcSEcCtD
Treprostinil—Haematuria—Epirubicin—testicular cancer	0.00157	0.00157	CcSEcCtD
Treprostinil—Dizziness—Ifosfamide—testicular cancer	0.00157	0.00157	CcSEcCtD
Treprostinil—Pharyngitis—Methotrexate—testicular cancer	0.00157	0.00157	CcSEcCtD
Treprostinil—Epistaxis—Epirubicin—testicular cancer	0.00156	0.00156	CcSEcCtD
Treprostinil—Sinusitis—Epirubicin—testicular cancer	0.00155	0.00155	CcSEcCtD
Treprostinil—Feeling abnormal—Etoposide—testicular cancer	0.00155	0.00155	CcSEcCtD
Treprostinil—Nausea—Dactinomycin—testicular cancer	0.00154	0.00154	CcSEcCtD
Treprostinil—Pneumonia—Doxorubicin—testicular cancer	0.00154	0.00154	CcSEcCtD
Treprostinil—Gastrointestinal pain—Etoposide—testicular cancer	0.00154	0.00154	CcSEcCtD
Treprostinil—Vomiting—Ifosfamide—testicular cancer	0.00151	0.00151	CcSEcCtD
Treprostinil—Bradycardia—Epirubicin—testicular cancer	0.00151	0.00151	CcSEcCtD
Treprostinil—Rash—Ifosfamide—testicular cancer	0.0015	0.0015	CcSEcCtD
Treprostinil—Dermatitis—Ifosfamide—testicular cancer	0.0015	0.0015	CcSEcCtD
Treprostinil—Haemoglobin—Epirubicin—testicular cancer	0.00149	0.00149	CcSEcCtD
Treprostinil—Rhinitis—Epirubicin—testicular cancer	0.00149	0.00149	CcSEcCtD
Treprostinil—Body temperature increased—Etoposide—testicular cancer	0.00148	0.00148	CcSEcCtD
Treprostinil—Abdominal pain—Etoposide—testicular cancer	0.00148	0.00148	CcSEcCtD
Treprostinil—Urinary tract infection—Doxorubicin—testicular cancer	0.00148	0.00148	CcSEcCtD
Treprostinil—Haemorrhage—Epirubicin—testicular cancer	0.00148	0.00148	CcSEcCtD
Treprostinil—Asthenia—Cisplatin—testicular cancer	0.00147	0.00147	CcSEcCtD
Treprostinil—Pharyngitis—Epirubicin—testicular cancer	0.00147	0.00147	CcSEcCtD
Treprostinil—Oedema peripheral—Epirubicin—testicular cancer	0.00146	0.00146	CcSEcCtD
Treprostinil—Haematuria—Doxorubicin—testicular cancer	0.00146	0.00146	CcSEcCtD
Treprostinil—Epistaxis—Doxorubicin—testicular cancer	0.00144	0.00144	CcSEcCtD
Treprostinil—Sinusitis—Doxorubicin—testicular cancer	0.00143	0.00143	CcSEcCtD
Treprostinil—Nausea—Ifosfamide—testicular cancer	0.00141	0.00141	CcSEcCtD
Treprostinil—Diarrhoea—Cisplatin—testicular cancer	0.0014	0.0014	CcSEcCtD
Treprostinil—Bradycardia—Doxorubicin—testicular cancer	0.0014	0.0014	CcSEcCtD
Treprostinil—Erythema—Methotrexate—testicular cancer	0.00138	0.00138	CcSEcCtD
Treprostinil—Haemoglobin—Doxorubicin—testicular cancer	0.00138	0.00138	CcSEcCtD
Treprostinil—Flushing—Epirubicin—testicular cancer	0.00138	0.00138	CcSEcCtD
Treprostinil—Rhinitis—Doxorubicin—testicular cancer	0.00137	0.00137	CcSEcCtD
Treprostinil—Haemorrhage—Doxorubicin—testicular cancer	0.00137	0.00137	CcSEcCtD
Treprostinil—Pharyngitis—Doxorubicin—testicular cancer	0.00136	0.00136	CcSEcCtD
Treprostinil—Oedema peripheral—Doxorubicin—testicular cancer	0.00135	0.00135	CcSEcCtD
Treprostinil—Asthenia—Etoposide—testicular cancer	0.00135	0.00135	CcSEcCtD
Treprostinil—Back pain—Methotrexate—testicular cancer	0.00133	0.00133	CcSEcCtD
Treprostinil—Pruritus—Etoposide—testicular cancer	0.00133	0.00133	CcSEcCtD
Treprostinil—Vomiting—Cisplatin—testicular cancer	0.0013	0.0013	CcSEcCtD
Treprostinil—Rash—Cisplatin—testicular cancer	0.00129	0.00129	CcSEcCtD
Treprostinil—Dermatitis—Cisplatin—testicular cancer	0.00129	0.00129	CcSEcCtD
Treprostinil—Erythema—Epirubicin—testicular cancer	0.00129	0.00129	CcSEcCtD
Treprostinil—Diarrhoea—Etoposide—testicular cancer	0.00129	0.00129	CcSEcCtD
Treprostinil—Ill-defined disorder—Methotrexate—testicular cancer	0.00128	0.00128	CcSEcCtD
Treprostinil—Anaemia—Methotrexate—testicular cancer	0.00127	0.00127	CcSEcCtD
Treprostinil—Flushing—Doxorubicin—testicular cancer	0.00127	0.00127	CcSEcCtD
Treprostinil—Tension—Epirubicin—testicular cancer	0.00127	0.00127	CcSEcCtD
Treprostinil—Nervousness—Epirubicin—testicular cancer	0.00125	0.00125	CcSEcCtD
Treprostinil—Back pain—Epirubicin—testicular cancer	0.00125	0.00125	CcSEcCtD
Treprostinil—Malaise—Methotrexate—testicular cancer	0.00124	0.00124	CcSEcCtD
Treprostinil—Dizziness—Etoposide—testicular cancer	0.00124	0.00124	CcSEcCtD
Treprostinil—Muscle spasms—Epirubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Treprostinil—Nausea—Cisplatin—testicular cancer	0.00122	0.00122	CcSEcCtD
Treprostinil—Cough—Methotrexate—testicular cancer	0.0012	0.0012	CcSEcCtD
Treprostinil—Ill-defined disorder—Epirubicin—testicular cancer	0.0012	0.0012	CcSEcCtD
Treprostinil—Vomiting—Etoposide—testicular cancer	0.00119	0.00119	CcSEcCtD
Treprostinil—Erythema—Doxorubicin—testicular cancer	0.00119	0.00119	CcSEcCtD
Treprostinil—Anaemia—Epirubicin—testicular cancer	0.00119	0.00119	CcSEcCtD
Treprostinil—Rash—Etoposide—testicular cancer	0.00118	0.00118	CcSEcCtD
Treprostinil—Dermatitis—Etoposide—testicular cancer	0.00118	0.00118	CcSEcCtD
Treprostinil—Headache—Etoposide—testicular cancer	0.00118	0.00118	CcSEcCtD
Treprostinil—Myalgia—Methotrexate—testicular cancer	0.00117	0.00117	CcSEcCtD
Treprostinil—Chest pain—Methotrexate—testicular cancer	0.00117	0.00117	CcSEcCtD
Treprostinil—Arthralgia—Methotrexate—testicular cancer	0.00117	0.00117	CcSEcCtD
Treprostinil—Tension—Doxorubicin—testicular cancer	0.00117	0.00117	CcSEcCtD
Treprostinil—Malaise—Epirubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Treprostinil—Discomfort—Methotrexate—testicular cancer	0.00116	0.00116	CcSEcCtD
Treprostinil—Nervousness—Doxorubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Treprostinil—Syncope—Epirubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Treprostinil—Back pain—Doxorubicin—testicular cancer	0.00115	0.00115	CcSEcCtD
Treprostinil—Muscle spasms—Doxorubicin—testicular cancer	0.00115	0.00115	CcSEcCtD
Treprostinil—Palpitations—Epirubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Treprostinil—Loss of consciousness—Epirubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Treprostinil—Cough—Epirubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Treprostinil—Infection—Methotrexate—testicular cancer	0.00112	0.00112	CcSEcCtD
Treprostinil—Nausea—Etoposide—testicular cancer	0.00112	0.00112	CcSEcCtD
Treprostinil—Ill-defined disorder—Doxorubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Treprostinil—Anaemia—Doxorubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Treprostinil—Thrombocytopenia—Methotrexate—testicular cancer	0.0011	0.0011	CcSEcCtD
Treprostinil—Myalgia—Epirubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Treprostinil—Arthralgia—Epirubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Treprostinil—Chest pain—Epirubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Treprostinil—Anxiety—Epirubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Treprostinil—Discomfort—Epirubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Treprostinil—Malaise—Doxorubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Treprostinil—Anorexia—Methotrexate—testicular cancer	0.00107	0.00107	CcSEcCtD
Treprostinil—Syncope—Doxorubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Treprostinil—Palpitations—Doxorubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Treprostinil—Oedema—Epirubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Treprostinil—Hypotension—Methotrexate—testicular cancer	0.00105	0.00105	CcSEcCtD
Treprostinil—Loss of consciousness—Doxorubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Treprostinil—Infection—Epirubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Treprostinil—Cough—Doxorubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Treprostinil—Shock—Epirubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Treprostinil—Thrombocytopenia—Epirubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Treprostinil—Tachycardia—Epirubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.00103	0.00103	CcSEcCtD
Treprostinil—Insomnia—Methotrexate—testicular cancer	0.00102	0.00102	CcSEcCtD
Treprostinil—Myalgia—Doxorubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Treprostinil—Chest pain—Doxorubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Treprostinil—Arthralgia—Doxorubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Treprostinil—Anxiety—Doxorubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Treprostinil—Paraesthesia—Methotrexate—testicular cancer	0.00101	0.00101	CcSEcCtD
Treprostinil—Discomfort—Doxorubicin—testicular cancer	0.001	0.001	CcSEcCtD
Treprostinil—Anorexia—Epirubicin—testicular cancer	0.001	0.001	CcSEcCtD
Treprostinil—Dyspnoea—Methotrexate—testicular cancer	0.001	0.001	CcSEcCtD
Treprostinil—Dyspepsia—Methotrexate—testicular cancer	0.00099	0.00099	CcSEcCtD
Treprostinil—Hypotension—Epirubicin—testicular cancer	0.000984	0.000984	CcSEcCtD
Treprostinil—Decreased appetite—Methotrexate—testicular cancer	0.000978	0.000978	CcSEcCtD
Treprostinil—Oedema—Doxorubicin—testicular cancer	0.000974	0.000974	CcSEcCtD
Treprostinil—Fatigue—Methotrexate—testicular cancer	0.00097	0.00097	CcSEcCtD
Treprostinil—Infection—Doxorubicin—testicular cancer	0.000968	0.000968	CcSEcCtD
Treprostinil—Pain—Methotrexate—testicular cancer	0.000962	0.000962	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000959	0.000959	CcSEcCtD
Treprostinil—Shock—Doxorubicin—testicular cancer	0.000959	0.000959	CcSEcCtD
Treprostinil—Thrombocytopenia—Doxorubicin—testicular cancer	0.000954	0.000954	CcSEcCtD
Treprostinil—Insomnia—Epirubicin—testicular cancer	0.000952	0.000952	CcSEcCtD
Treprostinil—Tachycardia—Doxorubicin—testicular cancer	0.000951	0.000951	CcSEcCtD
Treprostinil—Paraesthesia—Epirubicin—testicular cancer	0.000945	0.000945	CcSEcCtD
Treprostinil—Dyspnoea—Epirubicin—testicular cancer	0.000939	0.000939	CcSEcCtD
Treprostinil—Anorexia—Doxorubicin—testicular cancer	0.000929	0.000929	CcSEcCtD
Treprostinil—Feeling abnormal—Methotrexate—testicular cancer	0.000927	0.000927	CcSEcCtD
Treprostinil—Dyspepsia—Epirubicin—testicular cancer	0.000927	0.000927	CcSEcCtD
Treprostinil—Gastrointestinal pain—Methotrexate—testicular cancer	0.00092	0.00092	CcSEcCtD
Treprostinil—Decreased appetite—Epirubicin—testicular cancer	0.000915	0.000915	CcSEcCtD
Treprostinil—Hypotension—Doxorubicin—testicular cancer	0.00091	0.00091	CcSEcCtD
Treprostinil—Fatigue—Epirubicin—testicular cancer	0.000908	0.000908	CcSEcCtD
Treprostinil—Pain—Epirubicin—testicular cancer	0.0009	0.0009	CcSEcCtD
Treprostinil—Abdominal pain—Methotrexate—testicular cancer	0.000889	0.000889	CcSEcCtD
Treprostinil—Body temperature increased—Methotrexate—testicular cancer	0.000889	0.000889	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000888	0.000888	CcSEcCtD
Treprostinil—Insomnia—Doxorubicin—testicular cancer	0.000881	0.000881	CcSEcCtD
Treprostinil—Paraesthesia—Doxorubicin—testicular cancer	0.000875	0.000875	CcSEcCtD
Treprostinil—Dyspnoea—Doxorubicin—testicular cancer	0.000869	0.000869	CcSEcCtD
Treprostinil—Feeling abnormal—Epirubicin—testicular cancer	0.000868	0.000868	CcSEcCtD
Treprostinil—Gastrointestinal pain—Epirubicin—testicular cancer	0.000861	0.000861	CcSEcCtD
Treprostinil—Dyspepsia—Doxorubicin—testicular cancer	0.000858	0.000858	CcSEcCtD
Treprostinil—Decreased appetite—Doxorubicin—testicular cancer	0.000847	0.000847	CcSEcCtD
Treprostinil—Fatigue—Doxorubicin—testicular cancer	0.00084	0.00084	CcSEcCtD
Treprostinil—Pain—Doxorubicin—testicular cancer	0.000833	0.000833	CcSEcCtD
Treprostinil—Abdominal pain—Epirubicin—testicular cancer	0.000832	0.000832	CcSEcCtD
Treprostinil—Body temperature increased—Epirubicin—testicular cancer	0.000832	0.000832	CcSEcCtD
Treprostinil—Asthenia—Methotrexate—testicular cancer	0.000807	0.000807	CcSEcCtD
Treprostinil—Feeling abnormal—Doxorubicin—testicular cancer	0.000803	0.000803	CcSEcCtD
Treprostinil—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000797	0.000797	CcSEcCtD
Treprostinil—Pruritus—Methotrexate—testicular cancer	0.000796	0.000796	CcSEcCtD
Treprostinil—Abdominal pain—Doxorubicin—testicular cancer	0.00077	0.00077	CcSEcCtD
Treprostinil—Body temperature increased—Doxorubicin—testicular cancer	0.00077	0.00077	CcSEcCtD
Treprostinil—Diarrhoea—Methotrexate—testicular cancer	0.00077	0.00077	CcSEcCtD
Treprostinil—Asthenia—Epirubicin—testicular cancer	0.000755	0.000755	CcSEcCtD
Treprostinil—Pruritus—Epirubicin—testicular cancer	0.000745	0.000745	CcSEcCtD
Treprostinil—Dizziness—Methotrexate—testicular cancer	0.000744	0.000744	CcSEcCtD
Treprostinil—Diarrhoea—Epirubicin—testicular cancer	0.00072	0.00072	CcSEcCtD
Treprostinil—Vomiting—Methotrexate—testicular cancer	0.000715	0.000715	CcSEcCtD
Treprostinil—Rash—Methotrexate—testicular cancer	0.000709	0.000709	CcSEcCtD
Treprostinil—Dermatitis—Methotrexate—testicular cancer	0.000709	0.000709	CcSEcCtD
Treprostinil—Headache—Methotrexate—testicular cancer	0.000705	0.000705	CcSEcCtD
Treprostinil—Asthenia—Doxorubicin—testicular cancer	0.000699	0.000699	CcSEcCtD
Treprostinil—Dizziness—Epirubicin—testicular cancer	0.000696	0.000696	CcSEcCtD
Treprostinil—Pruritus—Doxorubicin—testicular cancer	0.000689	0.000689	CcSEcCtD
Treprostinil—Vomiting—Epirubicin—testicular cancer	0.000669	0.000669	CcSEcCtD
Treprostinil—Nausea—Methotrexate—testicular cancer	0.000668	0.000668	CcSEcCtD
Treprostinil—Diarrhoea—Doxorubicin—testicular cancer	0.000667	0.000667	CcSEcCtD
Treprostinil—Rash—Epirubicin—testicular cancer	0.000664	0.000664	CcSEcCtD
Treprostinil—Dermatitis—Epirubicin—testicular cancer	0.000663	0.000663	CcSEcCtD
Treprostinil—Headache—Epirubicin—testicular cancer	0.00066	0.00066	CcSEcCtD
Treprostinil—Dizziness—Doxorubicin—testicular cancer	0.000644	0.000644	CcSEcCtD
Treprostinil—Nausea—Epirubicin—testicular cancer	0.000625	0.000625	CcSEcCtD
Treprostinil—Vomiting—Doxorubicin—testicular cancer	0.000619	0.000619	CcSEcCtD
Treprostinil—Rash—Doxorubicin—testicular cancer	0.000614	0.000614	CcSEcCtD
Treprostinil—Dermatitis—Doxorubicin—testicular cancer	0.000614	0.000614	CcSEcCtD
Treprostinil—Headache—Doxorubicin—testicular cancer	0.00061	0.00061	CcSEcCtD
Treprostinil—Nausea—Doxorubicin—testicular cancer	0.000579	0.000579	CcSEcCtD
